IRMD
NASDAQ
Health Care
$97.03
USD
-$0.74 (-0.76%)
At close: Jul 17, 2026, 4:00 PM EDT
Market Cap:
$1.25B
Volume:
129.7K
Previous Close
$97.77
Day Range
$96.25 - $97.94
52 Week Range
$55.11 - $107.90
Average Volume (10 Days)
140.0K
P/E Ratio (TTM)
52.93
Dividend Yield
1.24%
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. The company is headquartered in Orlando, Florida and currently employs 166 full-time employees. The company went IPO on 2014-07-16. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The firm sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.
CEO
Mr. Roger Susi
Headquaters
Orlando, FLORIDA, US
Founded
2014
Employees
166